Cite
Lachaine J, Crott R. Cost-effectiveness of antiemetics use during cancer chemotherapy. Expert Rev Pharmacoecon Outcomes Res. 2003;3(3):263-72doi: 10.1586/14737167.3.3.263.
Lachaine, J., & Crott, R. (2003). Cost-effectiveness of antiemetics use during cancer chemotherapy. Expert review of pharmacoeconomics & outcomes research, 3(3), 263-72. https://doi.org/10.1586/14737167.3.3.263
Lachaine, Jean, and Crott, Ralph. "Cost-effectiveness of antiemetics use during cancer chemotherapy." Expert review of pharmacoeconomics & outcomes research vol. 3,3 (2003): 263-72. doi: https://doi.org/10.1586/14737167.3.3.263
Lachaine J, Crott R. Cost-effectiveness of antiemetics use during cancer chemotherapy. Expert Rev Pharmacoecon Outcomes Res. 2003 Jun;3(3):263-72. doi: 10.1586/14737167.3.3.263. PMID: 19807374.
Copy
Download .nbib